每年專案
個人檔案
學歷
- 2008 Rutgers UniversityPharmacology博士
- 1998 陽明大學生化碩士
- 1996 臺灣大學農業化學學士
經歷
- 2018- 臺北醫學大學癌症生物學與藥物研發研究所副教授
- 2018- 臺北醫學大學癌症生物學與藥物研發博士學位學程副教授
- 2013-2018 臺北醫學大學癌症生物學與藥物研發博士學位學程助理教授
- 2009-2013 Princeton University博士後研究員
研究興趣
- 去氧核糖核酸受損訊息,
- 抗癌研究
- 疫苗研究
相關連結
指紋
- 1 類似的個人檔案
網路
-
Disruption of CCL2 in Mesenchymal Stem Cells as an Anti-Tumor Approach against Prostate Cancer
Bui, Q. T., Lee, K. D., Fan, Y. C., Lewis, B. S., Deng, L. W. & Tsai, Y. C., 1月 2023, 於: Cancers. 15, 2, 441.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes
Tsai, Y. C., Huang, C. Y., Hsueh, Y. M., Fan, Y. C., Fong, Y. C., Huang, S. P., Geng, J. H., Chen, L. C., Lu, T. L. & Bao, B. Y., 6月 15 2021, 於: Life Sciences. 275, 119396.研究成果: 雜誌貢獻 › 文章 › 同行評審
1 引文 斯高帕斯(Scopus) -
Investigation of anti-tumor effects of an MLK1 inhibitor in prostate and pancreatic cancers
Fan, Y. C., Hsu, K. C., Lin, T. E., Zechner, D., Hsu, S. P. & Tsai, Y. C., 8月 2021, 於: Biology. 10, 8, 742.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取3 引文 斯高帕斯(Scopus) -
Roles of interleukin-1 receptor antagonist in prostate cancer progression
Fan, Y. C., Lee, K. D. & Tsai, Y. C., 12月 2020, 於: Biomedicines. 8, 12, p. 1-13 13 p., 602.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取3 引文 斯高帕斯(Scopus) -
Tumor-infiltrating leukocytes suppress local inflammation via interleukin-1 receptor antagonist in a syngeneic prostate cancer model
Fan, Y. C., Chen, W. Y., Lee, K. D. & Tsai, Y. C., 4月 2020, 於: Biology. 9, 4, 67.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取3 引文 斯高帕斯(Scopus)
資料集
-
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y. (Contributor), Zeng, T. (Creator), Abou-Kheir, W. (Creator), Yeh, H. (Contributor), Yin, J. J. (Creator), Lee, Y. (Creator), Chen, W. (Creator) & Liu, Y. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4008787.v1, https://doi.org/10.6084%2Fm9.figshare.c.4008787.v1
資料集: Dataset
-
Additional file 1: of Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y. (Contributor), Zeng, T. (Creator), Abou-Kheir, W. (Creator), Yeh, H. (Contributor), Yin, J. J. (Creator), Lee, Y. (Creator), Chen, W. (Creator) & Liu, Y. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.5900626.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Disruption_of_ETV6_leads_to_TWIST1-dependent_progression_and_resistance_to_epidermal_growth_factor_receptor_tyrosine_kinase_inhibitors_in_prostate_cancer/5900626/1
資料集: Dataset